Since HGF and NGF are recognized melanogenic paracrine factors associated with solar lentigo and melasma pathogenesis, common hyperpigmentary skin disorders 52-55, the anti-melanogenic activity of altiratinib could potentially be mediated by interfering with these signaling pathways. Here, HGF is linked to skin disorder.